Healthcare technology maker G Medical Innovations withdraws $30 million US IPO

G Medical Innovations Holdings, which provides app-connected medical devices for monitoring vital signs, withdrew its plans for an initial public offering on Tuesday. It had filed to raise $30 million by offering 5 million shares at a price range of $5 to $7. This was the company's second attempt to go public in the US, previously filing in May 2019 and withdrawing the following August. The company was also previously listed on the ASX (GMV) but recently delisted its shares.

The Rehovot, Israel-based company was founded in 2014 and booked $5 million in revenue for the 12 months ended June 30, 2020. It had planned to list on the Nasdaq under the symbol GMVD. Boustead Securities and Fosun Hani Securities were set to be the joint bookrunners on the deal.

The article Healthcare technology maker G Medical Innovations withdraws $30 million US IPO originally appeared on IPO investment manager Renaissance Capital's web site

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO), Renaissance International ETF (symbol: IPOS), or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.